Biosignal Group
bsg bsg bsg bsg bsg bsg bsg bsg bsg bsg bsg bsg
BSG News
June, 2013   Bio-Signal Group Co. has been selected as one of the 10 winners of PILOT Tech health NYC to receive a total of $100K to launch the microEEG® platform in the Emergency Department (ED) of New York Methodist Hospital. This disruptive technology utilizes disposable electrodes and a network of teleneurologists to provide a rapid, remote interpretation of an EEG to an ED physician. Incorporating this technology in the workup of ED patients with neurological emergencies has the potential to make a strong positive impact on the healthcare ecosystem by improving patient care and reducing costs. (Link)
March, 2013   The Story Collider features a podcast by Dr. André Fenton: "The twisting road from basic brain research to helping malaria patients." (Link)
January, 2013   The microEEG® system will be used to assess the effects of repeated sessions of Transcranial Direct Current Stimulation (tDCS) to the left dorsolateral prefrontal cortex on frequency of interictal discharges and seizure frequency on patients with temporal lobe epilepsy (TLE). The primary behavioral outcomes for this interventional study will be working memory and mood benefit. However, the microEEG® system will help determine if this form of non-invasive neuromodulation can be applied without worsening ictal or interictal activity in TLE patients. The two study sites are at New York University (NYU) Comprehensive Epilepsy Center and the Beth Israel Deaconess Medical Center/Harvard Medical School, Boston MA. The results of this study will have a significant clinical impact for the treatment of the cognitive and psychiatric comorbidities of patients with TLE.
September, 2012   BSG’s poster abstract on Inter- and Inra-rater reliability in EEG interpretations was selected as a "Best Poster" by the scientific advisory committee of the 10th European Congress on Epileptology in London (September 30th-October 4th 2012). (Link to poster)
For scientific instruments go to
About BSG
Bio-Signal Group’s (BSG) mission is to enable functional brain monitoring anywhere at any time, for everyone. Our initial solution is the microEEG® System, a small, wireless, easy-to-use brain monitoring system designed specifically for use in the Emergency Department.

BSG was founded in 2002 by Dr. André Fenton to commercialize a proprietary digital telemetry (DT) technology. Since its founding, BSG has worked on developing new applications for DT, and in recognition of the strength of its technology and team, has been awarded multiple competitive NIH grants for developing DT technology for these applications. These include "Wireless Recording of Wideband Neuronal Activity in Freely Moving Humans". . . More About BSG
microEEG® Videos
microEEG® System Demonstration
Dr. André Fenton demonstrates an early working prototype to the SUNY Board of Trustees.
microEEG® System vs. Standard EEG System
This side by side comparison demonstrates the ease-of-use and speed of the microEEG® System.